Research Articles

March 16, 2013  HIV Surveillance Report, Volume 23

March 1, 2011  This presentation focuses on the role of nursing student’s teaching patient’s during clinical rotations with emphasis on prevention measures to mitigate the spread of the influenza virus. It serves as a clinical resource for nursing student’s to promote prevention measures to fight against the influenza virus.

June 26, 2013  The human brain is the most complex organ in the body. The resulting effects on the brain's pleasure circuit dwarfs those produced by naturally rewarding behaviors such as eating and sex.

October 10, 2010  Health-e-Cards CDC has more than 100 free Health-e-Cards (or "electronic greeting cards") to send to friends, family, and co-workers! Simply select a CDC Health-e-Card, type in an email address and name, and send a colorful greeting that encourages healthy living, promotes safe activities, or celebrates a health- and safety-related event!

September 23, 2014  What is ZMapp? ZMapp, being developed by Mapp Biopharmaceutical Inc., is an experimental treatment, for use with individuals infected with Ebola virus. It has not yet been tested in humans for safety or effectiveness. The product is a combination of three different monoclonal antibodies that bind to the protein of the Ebola virus.

October 12, 2014  ...CDC confirms that the healthcare worker is positive for Ebola.

July 29, 2012  On May 14, 2011, the Ugandan Ministry of Health informed the public that a patient with suspected Ebola Hemorrhagic fever died on May 6, 2011 in the Luwero district, Uganda. CDC-Uganda confirmed a positive Ebola virus test result from a blood sample taken from the patient. The quick diagnosis of Ebola virus was provided by the new CDC Viral Hemorrhagic Fever laboratory installed at the Uganda Viral Research Institute (UVRI). On January 22, 2009, CDC's Viral Special Pathogens Branch retrospectively diagnosed a case of Marburg hemorrhagic fever in a U.S. traveler, who returned from Uganda in January, 2008. The patient developed illness four days after returning to the U.S., was hospitalized, discharged, and fully recovered. Initial testing of samples collected during the patient's acute illness in January, 2008 did not initially show evidence of Marburg virus infection. Testing of a convalescent sample indicated a possible previous infection, and more detailed testing of both samples at CDC confirmed that the patient's illness was due to Marburg hemorrhagic fever.

October 9, 2014  No FDA approved vaccine. Some people who have recovered from Ebola have developed long-term complications, such as joint and vision problems.

October 29, 2014  This updated guidance focuses on strengthening how we monitor people who may have been exposed to Ebola and how medical professionals will oversee their care and, when warranted to protect the public health or our communities, limit their movement or activities.

July 11, 2012  Armed with bracing logic, wit and her “public-health nerd” glasses, Elizabeth Pisani reveals the myriad of inconsistencies in today’s political systems that prevent our dollars from effectively fighting the spread of HIV.